Target intelligence / Profile preview

Intestinal epithelial cell membrane receptor (Multiple types, see below) (None; individual receptors (e.g., TLR2, NOD1) have their own abbreviations)

Target
None; individual receptors (e.g., TLR2, NOD1) have their own abbreviations
Molecular classification
Pattern recognition receptor (Toll-like receptor, NOD-like receptor, RIG-I-like receptor, C-type lectin receptor), Ion channel (e.g., epithelial sodium channel), Transporter (e.g., GLUT2, SGLT1), Enzyme (e.g., brush border enzymes like enteropeptidase), Cell adhesion/junctional protein (tight junction, adherens junction, desmosome, occludin, claudin), Other (receptors for cytokines, chemokines, G protein-coupled receptors)
01

Overview

Intestinal epithelial cell membrane receptors and complexes comprise a diverse group of molecules responsible for barrier formation, nutrient absorption, immune signaling, and cell-to-cell communication. Major families include pattern recognition receptors (e.g., TLRs, NOD-like receptors), various ion channels, transporters (such as GLUT2, SGLT1), brush border enzymes, and multiple adhesion and junctional proteins (tight junctions, adherens junctions, desmosomes). These components mediate physical separation from luminal pathogens, orchestrate innate and adaptive immune responses, regulate the uptake of nutrients, and maintain epithelial cell integrity. Dysregulation or aberrant activation of these receptors/complexes is linked to inflammatory diseases, infections, and cancer. Therapeutic targeting must be precise to avoid disrupting the finely balanced homeostatic functions of the intestinal epithelium[1][2][3][5][6].

Other names
Intestinal epithelial cell surface receptorsIEC membrane receptorsIntestinal pattern recognition receptors (subset)Intestinal transporters (subset)Tight junction proteins (subset)
02

Mechanism of action

Modulation of inflammatory signaling (PRR ligand binding, TLR inhibition/activation) Alteration of barrier integrity (tight junction stabilizers/destabilizers) Blockade or activation of nutrient transport (transporter inhibition/activation) Enzyme inhibition (brush border enzyme inhibitors)

03

Biological functions

Barrier function (tight junctions and cell adhesion complexes)Signal transduction (PRRs, TLR and NOD signaling)Immune response (activation of cytokine and chemokine secretion)Mucus production (goblet cell receptors)Antigen presentation (microfold cell receptors)Nutrient absorption (glucose, amino acid, bile acid transporters)Cell proliferation and death (regulatory signaling)
04

Disease associations

Inflammation (excessive PRR activation or barrier dysfunction)Infection (pathogen recognition, antimicrobial peptide secretion)Cancer (alteration of cell junctions and signaling, e.g., colon cancer)Other (autoimmune disorders, food allergies, metabolic disease)
05

Safety considerations

Broad modulation risks disturbing intestinal homeostasisRisk of impaired barrier function, leading to infections or increased inflammationOff-target immune activation may cause autoimmune disorders or chronic inflammationAltered nutrient absorption if transporters affected
06

Interacting drugs

PRR modulators (e.g., TLR agonists/antagonists—experimental)

2 more in the full profile.

07

Biomarkers

Cytokine and chemokine levels (e.g., IL-8, TNF-α)Tight junction protein expression (e.g., occludin, claudin)Antimicrobial peptide levels (e.g., defensins, RegIIIβ/γ)Mucin (MUC2) levelsPathogen-associated molecular patterns detection (PRR activation)

Beyond the preview

Go deeper on Intestinal epithelial cell membrane receptor (Multiple types, see below) (None; individual receptors (e.g., TLR2, NOD1) have their own abbreviations).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal epithelial cell membrane receptor (Multiple types, see below) (None; individual receptors (e.g., TLR2, NOD1) have their own abbreviations).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call